Catalogo dei prodotti della ricerca
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishCurrent pharmacological treatments of post-traumatic stress disorder (PTSD) have limited efficacy. Although the diagnosis is based on psychopathological criteria, it is frequently accompanied by somatic comorbidities and perhaps "accelerated biological aging," suggesting widespread physical concomitants. Such physiological comorbidities may affect core PTSD symptoms but are rarely the focus of therapeutic trials.
Novel Pharmacological Targets for Combat PTSD-Metabolism, Inflammation, The Gut Microbiome, and Mitochondrial Dysfunction / Bersani, F Saverio; Mellon, Synthia H; Lindqvist, Daniel; Kang, Jee In; Rampersaud, Ryan; Somvanshi, Pramod Rajaram; Doyle, Francis J; Hammamieh, Rasha; Jett, Marti; Yehuda, Rachel; Marmar, Charles R; Wolkowitz, Owen M. - In: MILITARY MEDICINE. - ISSN 0026-4075. - 185:Supplement_1(2020), pp. 311-318-318.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
| Titolo: | Novel Pharmacological Targets for Combat PTSD-Metabolism, Inflammation, The Gut Microbiome, and Mitochondrial Dysfunction | |
| Autori: | ||
| Data di pubblicazione: | 2020 | |
| Rivista: | ||
| Citazione: | Novel Pharmacological Targets for Combat PTSD-Metabolism, Inflammation, The Gut Microbiome, and Mitochondrial Dysfunction / Bersani, F Saverio; Mellon, Synthia H; Lindqvist, Daniel; Kang, Jee In; Rampersaud, Ryan; Somvanshi, Pramod Rajaram; Doyle, Francis J; Hammamieh, Rasha; Jett, Marti; Yehuda, Rachel; Marmar, Charles R; Wolkowitz, Owen M. - In: MILITARY MEDICINE. - ISSN 0026-4075. - 185:Supplement_1(2020), pp. 311-318-318. | |
| Abstract: | Current pharmacological treatments of post-traumatic stress disorder (PTSD) have limited efficacy. Although the diagnosis is based on psychopathological criteria, it is frequently accompanied by somatic comorbidities and perhaps "accelerated biological aging," suggesting widespread physical concomitants. Such physiological comorbidities may affect core PTSD symptoms but are rarely the focus of therapeutic trials. | |
| Handle: | http://hdl.handle.net/11573/1364237 | |
| Appartiene alla tipologia: | 01a Articolo in rivista |
File allegati a questo prodotto
| File | Note | Tipologia | Licenza | |
|---|---|---|---|---|
| Bersani_Novel Pharmacological Targets_2020.pdf | Versione editoriale (versione pubblicata con il layout dell'editore) | Tutti i diritti riservati (All rights reserved) | Administrator Richiedi una copia |
Copyright © 2021